Inotuzumab Ozogamicin (IO) and Donor Lymphocyte Infusion (DLI) are a Safe and Promising Combination in Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

被引：0
|
作者：
Papayannidis, Cristina [1 ]
Sartor, Chiara [2 ]
Dominietto, Alida [3 ]
Zappone, Elisabetta [4 ]
Marconi, Giovanni [2 ]
Abbenante, Maria Chiara [5 ]
Parisi, Sarah [2 ]
Robustelli, Valentina [2 ]
Terragna, Carolina [1 ]
Nanni, Jacopo [2 ]
Soverini, Simona [2 ]
Cristiano, Gianluca [2 ]
Arpinati, Mario [1 ]
Paolini, Stefania [1 ]
Martinelli, Giovanni [6 ]
Curti, Antonio [1 ]
Cavo, Michele [2 ]
Bonifazi, Francesca [1 ]
机构：
[1] Azienda Osped Univ St Orsola Malpighi, Ist Ematol, Bologna, Italy
[2] Univ Bologna Osped St Orsola Malpighi, Ist Ematol Seragnoli, Bologna, Italy
[3] IRCCS Osped Policlin San Martino, Genoa, Italy
[4] AOUS Siena, Policlin Scotte, UOC Ematol, Siena, Italy
[5] UOC Ematol, Casa Cura Sollievo Sofferenza, San Giovanni Rotondo, Italy
[6] IRST Ist Sci Romagnolo Cura & Studio Tumori, Meldola, Italy
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
acute lymphoblastic leukemia; ALL; inotuzumab ozogamicin; donor lymphocyte infusion;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ALL-073
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [31] Hematopoietic stem cell transplant (HSCT) versus intensive chemotherapy in infant acute lymphoblastic leukemia (ALL)
    Dreyer, Z. E.
    Dinndorf, P.
    Sather, H.
    Hilden, J. M.
    Devidas, M.
    Heerema, N. A.
    Smith, F. O.
    Carroll, W.
    Reaman, G.
    Camitta, B. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with gemtuzumab ozogamicin with a long interval followed by donor lymphocyte infusion
    H Tamai
    Y Shioi
    H Yamaguchi
    M Okabe
    S Wakita
    T Mizuki
    K Nakayama
    K Inokuchi
    K Tajika
    K Dan
    Leukemia, 2008, 22 : 1273 - 1274
  • [33] Outcomes of Adults with Acute Lymphoblastic Leukemia (ALL) Following Relapse After First Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
    Hamdi, Amir
    Poon, L. M.
    Saliba, Rima M.
    Rondon, Gabriela
    Ledesma, Celina
    Qazilbash, Muzaffar
    Hosing, Chitra M.
    Jones, Roy B.
    Popat, Uday R.
    Nieto
    Alousi, Amin M.
    Ciurea, Stefan O.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Kebriaei, Partow
    BLOOD, 2012, 120 (21)
  • [34] INFERIOR OUTCOME WITH ADDITION OF RITUXIMAB FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Kebriaei, P.
    Munsell, M.
    Gutierrez, K.
    de Lima, M.
    Giralt, S.
    Hosing, C.
    Popat, U.
    Qazilbash, M. H.
    Thomas, D.
    Kantarjian, H.
    Khouri, I. F.
    Champlin, R. E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 117 - 117
  • [35] Acute IgM warm autoimmune hemolytic anemia after unrelated peripheral blood hematopoietic stem cell transplantation (HSCT) and donor lymphocyte infusion (DLI)
    Yuan, S
    Gandhi, MJ
    Gernsheimer, T
    TRANSFUSION, 2005, 45 (03) : 132A - 132A
  • [36] Clinical Outcome with Allogeneic Hematopoietic Stem Cell Transplantation after Blinatumomab or Inotuzumab Ozogamicin in Patients with B-Cell Acute Lymphoblastic Leukemia: Real World Experience
    Badar, Talha
    Advani, Anjali S.
    Liedtke, Michaela
    Arslan, Shukaib
    Khan, Muhammad Ali
    Aldoss, Ibrahim
    Sienbenaller, Caitlin
    Schultz, Elizabeth
    Hefazi, Mehrdad
    Shallis, Rory Michael
    Yurkiewicz, Ilana
    Podoltsev, Nikolai
    Patel, Anand
    Curran, Emily
    Kuo, Eric
    Wang, Amy
    Balasubramanian, Suresh
    Yang, Jay
    Mattison, Ryan
    Burkart, Madelyn
    Dinner, Shira
    Litzow, Mark R.
    Wadleigh, Martha
    Atallah, Ehab
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S101 - S102
  • [37] Leukemia in donor cells after allogeneic hematopoietic stem cell transplant
    Brunstein, CG
    Hirsch, BA
    Hammerschmidt, D
    McGlennen, RC
    Nguyen, PL
    Verfaillie, CM
    BONE MARROW TRANSPLANTATION, 2002, 29 (12) : 999 - 1003
  • [38] Leukemia in donor cells after allogeneic hematopoietic stem cell transplant
    CG Brunstein
    BA Hirsch
    D Hammerschmidt
    RC McGlennen
    PL Nguyen
    CM Verfaillie
    Bone Marrow Transplantation, 2002, 29 : 999 - 1003
  • [39] Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
    Kaito Harada
    Shohei Mizuno
    Shingo Yano
    Akiyoshi Takami
    Hiroto Ishii
    Kazuhiro Ikegame
    Yuho Najima
    Shinichi Kako
    Takashi Ashida
    Souichi Shiratori
    Shuichi Ota
    Makoto Onizuka
    Kentaro Fukushima
    Takahiro Fukuda
    Tatsuo Ichinohe
    Yoshiko Atsuta
    Masamitsu Yanada
    Annals of Hematology, 2022, 101 : 643 - 653
  • [40] Azacitidine and donor lymphocyte infusion for patients with relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic stem cell transplantation: A meta-analysis
    Li, Xuefeng
    Wang, Wen
    Zhang, Xin
    Wu, Yu
    FRONTIERS IN ONCOLOGY, 2022, 12
12345